| Gene | Description | Sequences | Sequence assembly | Predicted SNPs having score >= 0.99 |
| ABL1 | V-abl Abelson murine leukemia viral oncogene homolog 1 | M14752, X16416 | X16416 | 4 |
| ABL2 | V-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | M35296 | ||
| ABR | Active BCR-related gene | L19704, U01147 | U01147 | |
| ACVR1B | Activin A receptor, type IB | Z22536 | ||
| ADK | Adenosine kinase | U50196 | U50196 | |
| ADRBK1 | Adrenergic, beta, receptor kinase 1 | M80776, U08435, U08436, U08437, U08438, X61157 | U08438 | |
| AK1 | Adenylate kinase 1 | J04809 | J04809 | 1 |
| AK2 | Adenylate kinase 2 | U39945, U54645 | U54645 | 3 |
| AK3 | Adenylate kinase 3 | X60673 | X60673 | 1 |
| AKT1 | V-akt murine thymoma viral oncogene homolog 1 | M63167 | M63167 | |
| AKT2 | V-akt murine thymoma viral oncogene homolog 2 | M77198, M95936 | M77198 | |
| ALOX12 | Arachidonate 12-lipoxygenase | M35418, M58704, M62982 | ||
| ALOX5 | Arachidonate 5-lipoxygenase | J03571, J03600 | J03600 | 1 |
| ARAF1 | V-raf murine sarcoma 3611 viral oncogene homolog 1 | L24038, U01337, X04790 | L24038 | |
| ARHA | Ras homolog gene family, member A | L09159, L25080, X05026 | L25080 | Location 1 (2) Location 2 (2) |
| ARHC | Ras homolog gene family, member C | L25081 | L25081 | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | L07916, L20688 | L20688 | 2 |
| BLK | B lymphoid tyrosine kinase | S76617, Z33998 | S76617 | 1 |
| BMPR2 | Bone morphogenetic protein receptor, type II (serine/threonine kinase) | D50516, Z48923 | Z48923 | |
| BMX | BMX non-receptor tyrosine kinase | X83107, AF045459 | ||
| BRAF | V-raf murine sarcoma viral oncogene homolog B1 | M95712, M95720, X54072 | M95712 | |
| BTK | Bruton agammaglobulinemia tyrosine kinase | U10087, X58957 | U01923 U78027 | 3 |
| CAK | Cell adhesion kinase | L20817, Z29093 | U48705 Z29093 | 1 |
| CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | M27319 | U12022 | 1 |
| CAMK4 | Calcium/calmodulin-dependent protein kinase IV | D30742 | ||
| CBLB | Cas-Br-M (murine) ectropic retroviral transforming sequence b | U26710, U26711, U26712 | U26710 | |
| CCNH | Cyclin H | U11791, U12685 | U11791 | |
| CDC2L1 | Cell division cycle 2-like 1 (PITSLRE proteins) | M37712, U04815 | M37712 | Location 1 (2) Location 2 (1) Location 3 (3) |
| CDC42 | Cell division cycle 42 (GTP-binding protein, 25kD) | M35543, M57298 | L10844 | 1 |
| CDC42 | Cell division cycle 42 (GTP-binding protein, 25kD) | M35543, M57298 | L10844 | 1 |
| CDC7L1 | CDC7 (cell division cycle 7, S. cerevisiae, homolog)-like 1 | AF015592 | AF015592 | |
| CDK2 | Cyclin-dependent kinase 2 | M68520, X61622, X62071 | M68520 | |
| CDK5 | Cyclin-dependent kinase 5 | X66364 | L04658 | 1 |
| CDK6 | Cyclin-dependent kinase 6 | X66365 | X66365 | |
| CDK7 | Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) | L20320, X77303, X77743, X79193 | L20320 | |
| CDK8 | Cyclin-dependent kinase 8 | X85753 | X85753 | |
| CDKN2B | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | L36844, U17075, AF004819 | ||
| CHEK1 | CHK1 (checkpoint, S.pombe) homolog | AF016582 | AF016582 | |
| CHN1 | Chimerin (chimaerin) 1 | X51408, Z22641 | X51408 | 1 |
| CHN2 | Chimerin (chimaerin) 2 | U28926 | U07223 | 1 |
| CHUK | Conserved helix-loop-helix ubiquitous kinase | AF009225 | ||
| CIS4 | STAT induced STAT inhibitor-4 | AB006968 | ||
| CKS1 | CDC28 protein kinase 1 | X54941 | X54941 | 1 |
| CKS2 | CDC28 protein kinase 2 | X54942 | X54942 | 1 |
| CLGN | Calmegin | D86322 | D86322 | |
| CLK2 | CDC-like kinase 2 | AF023268 | AF023268 J03060 L29218 U46920 | |
| CLK3 | CDC-like kinase 3 | L29217 | L29217 | |
| CNK | Cytokine-inducible kinase | U56998 | U56998 | |
| COT | Cot (cancer Osaka thyroid) oncogene | D14497 | D14497 | 1 |
| CSK | C-src tyrosine kinase | X60114 | X60114 | 2 |
| CSNK1A1 | Casein kinase 1, alpha 1 | L37042, X80693 | L37042 | 1 |
| CSNK1D | Casein kinase 1, delta | U29171 | U29171 | |
| CSNK1E | Casein kinase 1, epsilon | L37043 | L37043 | |
| CSNK2A2 | Casein kinase 2, alpha prime polypeptide | M55268 | M55268 | |
| CSNK2B | Casein kinase 2, beta polypeptide | M30448 | ||
| CTNNA1 | Catenin (cadherin-associated protein), alpha 1 (102kD) | D14705, L23805 | U03100 | Location 1 (1) Location 2 (1) |
| CTNNB1 | Catenin (cadherin-associated protein), beta 1 (88kD) | X87838, Z19054 | X87838 | |
| CTNND2 | Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein) | U52828, U96136 | U96136 | |
| DGKA | Diacylglycerol kinase, alpha (80kD) | X62535, AF064767 | X62535 | |
| DGKG | Diacylglycerol kinase, gamma (90kD) | AF020945 | D26135 | |
| DGKQ | Diacylglycerol kinase, theta (110kD) | L38707 | ||
| DMPK | Dystrophia myotonica-protein kinase | L08835, L19268 | L08835 | 1 |
| DRG2 | Developmentally regulated GTP-binding protein 2 | X80754 | X80754 | 1 |
| DVL3 | Dishevelled 3 (homologous to Drosophila dsh) | U49262, AF006013 | D86963 | |
| DYRK1 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1 | D85759, D86550, U52373, U58496, AB015282 | D86550 | 1 |
| DYRK1B | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | Y17999 | Y17999 | |
| DYRK2 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | Y09216, Y13493 | Y13493 | Location 1 (1) Location 2 (1) |
| DYRK3 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | Y12735 | Y12735 | |
| DYRK4 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | Y09305 | Y09305 | |
| EFNA1 | Ephrin-A1 | M57730 | M57730 | 3 |
| EFNA5 | Ephrin-A5 | U26403 | ||
| EFNB1 | Ephrin-B1 | U09303 | U09303 | 1 |
| EFNB2 | Ephrin-B2 | U16797 | U81262 | |
| EGFR | Epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog) | X00588 | X00588 | |
| EPHA2 | EphA2 | M59371 | M59371 | |
| EPHA4 | EphA4 | L36645 | ||
| EPHA5 | EphA5 | L36644 | ||
| EPHA7 | EphA7 | L36642 | ||
| EPHB3 | EphB3 | X75208 | X75208 | |
| EPHB4 | EphB4 | U07695 | U07695 | |
| EPHB6 | EphB6 | D83492 | D83492 | |
| ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) | M11730, X03363 | M11730 | |
| ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | M29366, M34309, S61953 | S61953 M34309 | |
| ERBB4 | V-erb-a avian erythroblastic leukemia viral oncogene homolog-like 4 | L07868 | ||
| FBL | Fibrillarin | M59849, X56597 | X56597 | |
| FER | Fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) | J03358 | ||
| FES | Feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog | X06292 | ||
| FGFR1 | Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | M34185, M34641 | X66945 | |
| FGFR2 | Fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) | M87770, M87771 | M87770 | 1 |
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | M12502, M19722 | M19722 | |
| FLT1 | Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | S77812, S77814, X51602 | X51602 | |
| FLT3LG | Fms-related tyrosine kinase 3 ligand | U03858, U04806 | ||
| FLT4 | Fms-related tyrosine kinase 4 | X68203, X69878 | ||
| FRK | Fyn-related kinase | U00803, U22322 | ||
| FYB | FYN-binding protein (FYB-120/130) | AF001862, AF001863 | AF001862 | |
| FYN | FYN oncogene related to SRC, FGR, YES | M14333, M14676 | Z97989 | |
| GLA | Galactosidase, alpha | U78027, X14448 | U01923 U78027 | 3 |
| GNAI1 | Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | J03005, M27543 | M27543 | 1 |
| GNG10 | Guanine nucleotide binding protein 10 | U31383 | U31383 | 1 |
| GPRK6 | G protein-coupled receptor kinase 6 | L16862 | L16862 | |
| GRB2 | Growth factor receptor-bound protein 2 | L29511, M96995 | M96995 | |
| GUCY1B3 | Guanylate cyclase 1, soluble, beta 3 | X66533 | X66533 | 2 |
| HCK | Hemopoietic cell kinase | M16591, M16592 | M16591 | |
| HIPK3 | Homeodomain-interacting protein kinase 3 | Y09306, AF004849 | AF004849 | |
| HRK | Harakiri, BCL2-interacting protein (contains only BH3 domain) | U76376 | ||
| ILK | Integrin-linked kinase | U40282 | U40282 | |
| IRAK1 | Interleukin-1 receptor-associated kinase 1 | L76191 | L76191 U52112 | |
| IRAK2 | Interleukin-1 receptor-associated kinase 2 | AF026273 | ||
| ITPKB | Inositol 1,4,5-trisphosphate 3-kinase B | X57206 | X57206 | |
| JAK1 | Janus kinase 1 (a protein tyrosine kinase) | M64174 | M64174 | |
| JAK2 | Janus kinase 2 (a protein tyrosine kinase) | AF005216 | ||
| JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | U09607 | ||
| KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | L04947, X61656 | AF035121 | |
| KIAA0641 | Apoptosis-associated tyrosine kinase | AB014541 | ||
| LCAT | Lecithin-cholesterol acyltransferase | M12625, X04981 | ||
| LCK | Lymphocyte-specific protein tyrosine kinase | M36881, U07236 | X05027 | |
| LIMK1 | LIM domain kinase 1 | D26309, U63721 | M36860 U63721 | 1 |
| LIMK2 | LIM domain kinase 2 | D45906 | D45906 | |
| LTK | Leukocyte tyrosine kinase | D16105, X60702 | ||
| LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog | M16038 | M16038 | 1 |
| MACS | Myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L) | D10522, M68956 | D10522 | 2 |
| MADH1 | MAD (mothers against decapentaplegic, Drosophila) homolog 1 | U59912 | U59423 | 1 |
| MADH2 | MAD (mothers against decapentaplegic, Drosophila) homolog 2 | AF027964 | U68018 | 1 |
| MADH3 | MAD (mothers against decapentaplegic, Drosophila) homolog 3 | U68019 | U68019 | |
| MAPKAPK2 | Mitogen-activated protein kinase-activated protein kinase 2 | U12779, X75346 | U12779 | 1 |
| MAPKAPK5 | Mitogen-activated protein kinase-activated protein kinase 5 | AF032437, AG032437 | AF032437 | |
| MATK | Megakaryocyte-associated tyrosine kinase | L18974, S75168 | ||
| MEKK3 | MAP/ERK kinase kinase 3 | U78876 | ||
| MEKK4 | MAP/ERK kinase kinase 4 | D86968, AF002715 | D86968 | 1 |
| MEKK5 | MAP/ERK kinase kinase 5 | D84476, U67156 | U67156 | 2 |
| MST1R | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | X70040 | X70040 | |
| NCK1 | NCK adaptor protein 1 | X17576 | X17576 | |
| NEK3 | NIMA (never in mitosis gene a)-related kinase | Z29067 | Z29067 | 1 |
| NME1 | Non-metastatic cells 1, protein (NM23A) expressed in | X17620 | X17620 | |
| NME2 | Non-metastatic cells 2, protein (NM23B) expressed in | L16785, X58965 | M36981 | 1 |
| NMI | N-myc (and STAT) interactor | U32849 | U32849 | 1 |
| NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) | J02590, M23613, M26697 | U89322 | 1 |
| NTRK1 | Neurotrophic tyrosine kinase, receptor, type 1 | X03541, Y09028, Y09029, Y09030, Y09031, Y09032, Y09033, Y09034, Y09035, Y09036, AB019488 | M23102 AC004079 | |
| NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | U12140 | U12140 | |
| NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | U05012 | U05012 | |
| NTRKR1 | Neurotrophic tyrosine kinase, receptor-related 1 | M97675, U38894 | M97675 | 3 |
| NTRKR2 | Neurotrophic tyrosine kinase, receptor-related 2 | M97639 | M97639 | |
| NTRKR3 | Neurotrophic tyrosine kinase, receptor-related 3 | X74764 | X74764 | 1 |
| PCTK3 | PCTAIRE protein kinase 3 | X66362 | X66362 | 2 |
| PDE4B | Phosphodiesterase 4B, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E4) | L12686, L20966, L20971, U85048 | L20971 | |
| PDGFA | Platelet-derived growth factor alpha polypeptide | M20488, M20489, M20490, M20491, M20492, M20493, M20494, X03795, X06374 | X06374 | |
| PDGFB | Platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | K01913, K01914, K01915, K01916, K01917, M12783 | M12783 | |
| PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | D50001, D50002, D50003, D50004, D50005, D50006, D50007, D50008, D50009, D50010, D50011, D50012, D50013, D50014, D50015, D50016, D50017, M21574 | M21574 | |
| PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | J03278, M21616 | J03278 | 2 |
| PDGFRL | Platelet-derived growth factor receptor-like | D37965 | D37965 | 1 |
| PDK2 | Pyruvate dehydrogenase kinase, isoenzyme 2 | L42451 | L42451 | 2 |
| PDK4 | Pyruvate dehydrogenase kinase, isoenzyme 4 | U54617 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | Y15056 | AF017995 | 1 |
| PHKA2 | Phosphorylase kinase, alpha 2 (liver), glycogen storage disease IX | D38616, X80497 | X80497 | |
| PHKG2 | Phosphorylase kinase, gamma 2 (testis) | M31606, Y11950, Y11951 | M31606 | |
| PIASX-BETA | Protein inhibitor of activated STAT X | AF077953, AF077954 | AF077954 | |
| PIK3C3 | Phosphoinositide-3-kinase, class 3 | Z46973 | Z46973 | 1 |
| PIK3CA | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | Z29090 | Z29090 | |
| PIK3CA | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | Z29090 | Z29090 | |
| PIK3CG | Phosphoinositide-3-kinase, catalytic, gamma polypeptide | X83368 | X83368 | |
| PIM1 | Pim-1 oncogene | M16750, M24779, M54915 | M54915 | 3 |
| PLA2G2A | Phospholipase A2, group IIA (platelets, synovial fluid) | M22430 | M22430 | 3 |
| PLCB4 | Phospholipase C, beta 4 | L41349 | AL031652 | |
| PLCE | Phospholipase C, epsilon | D42108 | D42108 | |
| PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | M37238 | M37238 | 1 |
| PPP2R5A | Protein phosphatase 2, regulatory subunit B (B56), alpha isoform | L42373 | L42373 | 2 |
| PPP2R5B | Protein phosphatase 2, regulatory subunit B (B56), beta isoform | L42374 | L42374 | |
| PPP2R5C | Protein phosphatase 2, regulatory subunit B (B56), gamma isoform | L42375 | ||
| PPP2R5D | Protein phosphatase 2, regulatory subunit B (B56), delta isoform | L76702 | L76702 | 1 |
| PPP2R5E | Protein phosphatase 2, regulatory subunit B (B56), epsilon isoform | L76703 | L76703 | |
| PRKAA2 | Protein kinase, AMP-activated, alpha 2 catalytic subunit | U06454 | ||
| PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | X07767 | X07767 | 1 |
| PRKACB | Protein kinase, cAMP-dependent, catalytic, beta | M34181 | M34181 | |
| PRKACG | Protein kinase, cAMP-dependent, catalytic, gamma | M34182 | ||
| PRKAG1 | Protein kinase, AMP-activated, gamma 1 non-catalytic subunit | U42412 | U42412 | |
| PRKAR1A | Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | M18468, M33336 | M33336 | 4 |
| PRKAR1B | Protein kinase, cAMP-dependent, regulatory, type I, beta | M65066 | M65066 | Location 1 (2) Location 2 (1) |
| PRKAR2B | Protein kinase, cAMP-dependent, regulatory, type II, beta | M31158 | M31158 | 1 |
| PRKCA | Protein kinase C, alpha | X52479 | X52479 | |
| PRKCB1 | Protein kinase C, beta 1 | X06318 | X07109 | |
| PRKCG | Protein kinase C, gamma | M13977, Z15114 | ||
| PRKCI | Protein kinase C, iota | L18964 | L33881 | |
| PRKCL1 | Protein kinase C-like 1 | S75546 | U33053 | 2 |
| PRKCL2 | Protein kinase C-like 2 | U33052 | U33052 | |
| PRKCM | Protein kinase C, mu | X75756 | X75756 | 1 |
| PRKCQ | Protein kinase C, theta | L01087 | L01087 | |
| PRKCZ | Protein kinase C, zeta | L14283, Z15108 | Z15108 | 1 |
| PRKG1 | Protein kinase, cGMP-dependent, type I | Y07512 | ||
| PRKG2 | Protein kinase, cGMP-dependent, type II | X94612 | ||
| PRKM1 | Protein kinase, mitogen-activated 1 (MAP kinase 1; p40, p41) | Z11694, Z11695 | Z11695 | 1 |
| PRKM10 | Protein kinase mitogen-activated 10 (MAP kinase) | U07620 | U07620 | |
| PRKM11 | Protein kinase mitogen- activated 11 | Y14440 | ||
| PRKM13 | Protein kinase mitogen- activated 13 | Y10488 | AF004709 | |
| PRKM3 | Protein kinase, mitogen-activated 3 (MAP kinase 3; p44) | M84490, Z11696 | X60188 | 3 |
| PRKM4 | Protein kinase, mitogen-activated 4 (MAP kinase 4; p63) | X59727 | X59727 | 1 |
| PRKM6 | Protein kinase, mitogen-activated 6 (extracellular signal-regulated kinase, p97) | L77964, X80692 | X80692 | |
| PRKM7 | Protein kinase mitogen-activated 7 (MAP kinase) | U25278 | ||
| PRKM8 | Protein kinase mitogen-activated 8 (MAP kinase) | L26318 | ||
| PRKM9 | Protein kinase mitogen-activated 9 (MAP kinase) | L31951, U34821 | U09759 | 2 |
| PRKMK1 | Protein kinase, mitogen-activated, kinase 1 (MAP kinase kinase 1) | L11284 | L11284 | 3 |
| PRKMK1 | Protein kinase, mitogen-activated, kinase 1 (MAP kinase kinase 1) | L11284 | L11284 | 3 |
| PRKMK2 | Protein kinase, mitogen-activated, kinase 2, p45 (MAP kinase kinase 2) | L11285 | L11285 | 4 |
| PRKMK3 | Protein kinase, mitogen-activated, kinase 3 (MAP kinase kinase 3) | D87116, L36719 | D87116 | |
| PRKMK5 | Protein kinase, mitogen-activated, kinase 5 (MAP kinase kinase 5) | U25265 | U25265 | 1 |
| PRKMK7 | Protein kinase, mitogen-activated, kinase 7 (MAP kinase kinase 7) | AF022805 | AF013589 | |
| PRKR | Protein kinase, interferon-inducible double stranded RNA dependent | M35663 | M35663 | |
| PTK2 | PTK2 protein tyrosine kinase 2 | L05186 | ||
| PTK2B | Protein tyrosine kinase 2 beta | L49207, U33284 | U43522 | |
| PTK7 | PTK7 protein tyrosine kinase 7 | U33635, U40271 | U33635 | |
| PTK9 | Protein tyrosine kinase 9 | U02680 | U02680 | |
| RAB8IP | Rab8 interacting protein (GC kinase) | U07349 | U07349 | |
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | M23379 | M23379 | |
| RET | Ret proto-oncogene (multiple endocrine neoplasia MEN2A, MEN2B and medullary thyroid carcinoma 1, Hirschsprung disease) | X15262 | ||
| RGS1 | Regulator of G-protein signalling 1 | S59049, X73427 | S59049 | |
| RGS16 | Regulator of G-protein signalling 16 | U70426 | U70426 | |
| RGS7 | Regulator of G-protein signalling 7 | U32439 | U32439 | |
| RHO7 | GTP-binding protein Rho7 | L78833, X95456 | U18009 U72882 L78833 | Location 1 (2) Location 2 (2) Location 3 (1) |
| RHOK | Rhodopsin kinase | U63973 | ||
| ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | U43195 | U43195 | 6 |
| RPS6KA2 | Ribosomal protein S6 kinase, 90kD, polypeptide 2 | L07598, X85106 | ||
| RPS6KB1 | Ribosomal protein S6 kinase, 70kD, polypeptide 1 | M60724, M60725 | M60724 | |
| RYK | RYK receptor-like tyrosine kinase | S59184, X69970 | S59184 | 2 |
| SAPK3 | Stress-activated protein kinase 3 | U66243, X79483 | ||
| SERK1 | SAPK/Erk kinase 1 | L36870, U17743 | L36870 | |
| SFN | Stratifin | AF029082 | X57348 | |
| SH2D1A | SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) | AL023657 | AL023657 AL022718 | 1 |
| SH3D1B | SH3 domain protein 1B | U61167 | U61167 | |
| SRC | V-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | K03218 | ||
| SRPK2 | SFRS protein kinase 2 | U88666 | U88666 | |
| SSI-1 | JAK binding protein | U88326, AB000676, AB000734, AB005043 | AB000734 | |
| SSI-3 | STAT induced STAT inhibitor 3 | AB004904, AB006967 | AB004904 | 1 |
| STAT1 | Signal transducer and activator of transcription 1, 91kD | U18662, U18663, U18664, U18665, U18666, U18667, U18668, U18669, U18670 | ||
| STAT2 | Signal transducer and activator of transcription 2, 113kD | U18671 | U18671 | |
| STAT3 | Signal transducer and activator of transcription 3 (acute-phase response factor) | L29277 | L29277 | |
| STAT4 | Signal transducer and activator of transcription 4 | L78440 | L78440 | |
| STAT5A | Signal transducer and activator of transcription 5A | L41142, U43185, U47686 | U43185 U47686 | |
| STAT6 | Signal transducer and activator of transcription 6, interleukin-4 induced | AF067572, AF067573 | ||
| STATI2 | STAT induced STAT inhibitor-2 | AB004903, AB006966, AF037989 | AF037989 | 1 |
| STK11 | Serine/threonine kinase 11 (Peutz-Jeghers syndrome) | AF032986, AF035625 | AF032986 | |
| STK15 | Serine/threonine kinase 15 | D84212, AF008551, AF011467, AF011468 | AF011468 | 1 |
| STK17A | Serine/threonine kinase 17a (apoptosis-inducing) | AB011420 | AC005189 AB011420 | 1 |
| STK17B | Serine/threonine kinase 17b (apoptosis-inducing) | AB011421 | AB011421 | |
| STK2 | Serine/threonine kinase 2 | L20321 | L20321 | 1 |
| STK3 | Serine/threonine kinase 3 (Ste20, yeast homolog) | U26424 | U26424 | |
| STK4 | Serine/threonine kinase 4 | U60207 | U60207 | |
| SUB1.5 | Guanine nucleotide exchange factor; 115-kD; mouse Lsc homolog | U64105 | U64105 | |
| SYK | Spleen tyrosine kinase | L28824 | L28824 | 1 |
| TESK1 | Testis-specific kinase 1 | D50863 | D50863 | |
| TIAM1 | T-cell lymphoma invasion and metastasis 1 | U16296 | ||
| TK2 | Thymidine kinase 2, mitochondrial | U77088, Y10498 | ||
| TNFAIP1 | Tumor necrosis factor, alpha-induced protein 1 (endothelial) | M59465 | M59465 | 1 |
| TRK | Oncogene TRK | |||
| TRK1 | TRNA lysine 1 | |||
| TTK | TTK protein kinase | M86699 | M86699 | |
| TXK | TXK tyrosine kinase | L27071 | L27071 | |
| TYK2 | Tyrosine kinase 2 | X54637 | X54637 | |
| TYRO3 | TYRO3 protein tyrosine kinase | U18934 | U18934 | 1 |
| TYROBP | TYRO protein tyrosine kinase binding protein | AF019563 | AF019562 | 2 |
| UBE1L | Ubiquitin-activating enzyme E1, like | L13852 | L13852 | |
| UBE2A | Ubiquitin-conjugating enzyme E2A (RAD6 homolog) | M74524 | M74524 | 1 |
| UBE2B | Ubiquitin-conjugating enzyme E2B (RAD6 homolog) | M74525, X53251 | M74525 | |
| VASP | Vasodilator-stimulated phosphoprotein | Z46389 | Z46389 | 2 |
| VAV2 | Vav 2 oncogene | S76992 | ||
| VRK2 | Vaccinia related kinase 2 | AB000450 | AB000450 | |
| WAS | Wiskott-Aldrich syndrome (ecezema-thrombocytopenia) | U12707, U19927 | U12707 | |
| YES1 | V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | M15990 | M15990 | |
| YESP | V-yes-1 Yamaguchi sarcoma viral oncogene homolog pseudogene | |||
| ZAP70 | Zeta-chain (TCR) associated protein kinase (70 kD) | L05148 | ||
| ZPK | Zipper (leucine) protein kinase | U07358 | U07358 |